Skip to main content

Chemotherapy Usually Intended for Dogs is Treating a Red Fox’s Lymphoma

Purdue Veterinary Hospital and Wolf Park Collaborate to Treat an Unusual Patient

Chris sits beside Joker the fox holding out his hand as Joker stands on a log looking up at him
The most rewarding part of Joker’s treatment, for Dr. Chris Fulkerson, has been seeing his tumors responding and watching him live his life as normal. (Purdue University photo/John Underwood)

The Purdue University Veterinary Hospital works with many patients across species. None are more unusual perhaps than Joker, an eight-year-old silver-phased red fox undergoing treatment for lymphoma. Joker resides at Wolf Park, a nonprofit conservation facility located in nearby Battle Ground, Ind.

During a routine medical check in November, his handler, Kimber Hendrix, noticed small tumors on his tongue.  Wolf Park’s veterinarian, Dr. Julia Becker, sent a biopsy to the Animal Disease Diagnostic Laboratory at the Purdue University College of Veterinary Medicine, where Joker was diagnosed with T-cell lymphoma by Dr. Mario Sola, assistant professor of diagnostic pathology.  Dr. Becker then referred Joker’s case to Dr. Christopher Fulkerson, clinical assistant professor of veterinary medical oncology in the College of Veterinary Medicine. 

Dr. Fulkerson hadn’t previously worked with a fox patient. He and his team couldn’t find any literature about this type of lymphoma in foxes, so they are treating Joker based on a protocol often used for dogs with lymphoma. This chemotherapy protocol mainly uses chemotherapy pills, which the team thought was most likely to be well-tolerated and successful.

According to Dr. Fulkerson, Joker’s behavior is similar to that of a dog. He is as wild as possible at Wolf Park, but is social and trained for medical procedures. “He’s a really laid-back fox,” Hendrix said. “He’s a sweet guy to work with. He’s a great animal ambassador.”

Joker has been at Wolf Park since 2015, when he was rescued after being found under a porch. His laid back personality – accompanied with a knack of playing practical jokes on his den mate Scarlette – make him a favorite among visitors.

Chris wears a mask outside at Wolf Park as he holds out an egg that Joker the fox puts in his mouth
After a treatment at Wolf Park, Dr. Chris Fulkerson rewards Joker with his favorite treat: an egg. (Purdue University photo/John Underwood)

To minimize his stress and anxiety, as many procedures as possible are followed at Wolf Park. Since January, Dr. Fulkerson has been going to Wolf Park almost weekly to administer Joker’s treatment and check his laboratory reports. On these days, Joker is rewarded with a special treat: an egg.

Joker is responding well to chemotherapy. After a few weeks of treatment, his lymphoma is in partial remission, meaning most of the lesions have gone away or have substantially decreased in size. He is undergoing chemotherapy treatments until mid-April. The hope is that over time, complete remission is achieved with the disappearance of all lesions, although the treatment time frame may be extended if lesions remain.

“We follow his lab work really closely to make sure that the chemotherapy drugs aren’t having any adverse effects on his white blood cell count. This drug can also cause liver injury, so we monitor his liver function and liver values. That all has been good throughout all the treatment, with no signs of obvious chemotherapy side effects,” Dr. Fulkerson said.

In captivity, red foxes can live 12-14 years. Each day, Joker engages in training and enrichment with staff and volunteers, and he has plenty of energy to play with his enrichment objects. Hendrix said that even during treatment, he hasn’t had any bad days.

Dr. Fulkerson said that the most gratifying and exciting part of Joker’s treatment has been seeing his tumors responding and seeing him living his life as normal.

“I was wearing my mask because of COVID-19,” he said of a recent visit, “But I told his handlers if they could have seen my face under it, I probably had one of the biggest smiles I’d had in the last year just from seeing him frolicking around and being excited and happy.”

Dr. Fulkerson treats Joker the fox as his handler holds him on an exam table in the Purdue University Veterinary Hospital
Dr. Chris Fulkerson, clinical assistant professor of veterinary medical oncology, treats Joker, a silver-phased red fox, at the Purdue University Veterinary Hospital. (Purdue University photo/John Underwood)

Purdue has offset the cost of some of Joker’s procedures with teaching funds. Joker’s lymphoma already has been a good learning case for diagnostic imaging, oncology, and pathology.  Following Joker’s progress may help with treatment of similar cases in the future.

The remaining costs, as of now, have been fully funded through donations to Wolf Park, although more need may arise in the future if his treatment is extended.

Hendrix said she’s thankful that Wolf Park has been able to partner with Purdue on Joker’s treatment.

“I just really have loved the partnership that has blossomed between Wolf Park and Purdue throughout this,” she said. “I’d love for there to be something that comes out of this to help other exotics so that people learn more about the progression of the disease, can help other animals in human care and can do more for them. Anything that can be learned from his case would be wonderful.”

Dr. Fulkerson agrees. He and his team plan to compile a case report on Joker so that this treatment option is documented to help other foxes diagnosed with lymphoma in the future.

“One of the great things about being at Purdue and being an academic veterinarian is that we can see some of these unusual things, we have some resources we can bring to help us learn about them, and then we can share that information with other veterinarians to help other patients in the future,” he said.

Click here to view a full Purdue news release.

Writer(s): Kelsey Lefever, Purdue Marketing and Communications | pvmnews@purdue.edu

Recent Stories

Retreat brings together Veterinary Technology team members 

Members of the Purdue Veterinary Technology Distance Learning (VTDL) Program team recently traveled to Purdue’s West Lafayette campus for an in-person retreat where they could work together and explore new opportunities for teaching, learning, and student success. The two day retreat focused on strengthening collaboration between the program's remote and on-campus teams, and represented a significant milestone for the program.

Annual Purdue Veterinary Conference draws veterinary professionals from across the country for learning and fun

The 2026 edition of the annual Purdue Veterinary Conference attracted attendees from around the U.S. for three days of educational sessions covering an array of topics.  With the overall theme of “One Health: Modern Veterinary Medicine,” the conference September 23-26 on the Purdue University campus drew more than 450 veterinarians and veterinary technicians, plus faculty, staff and students. Sessions taught by a total of 65 speakers, including many Purdue Veterinary Medicine clinicians and veterinary technicians/technologists, enabled conference-goers to earn up to 23 continuing education credit hours.

Significant Gift from Jordan Smelski Foundation will fuel Purdue Veterinary Medicine research on deadly brain eating amoeba

A researcher in the Purdue University College of Veterinary Medicine’s Department of Comparative Pathobiology has received a generous gift of more than $100,000 from the Jordan Smelski Foundation for Amoeba Awareness and Mr. Steve Smelski to support research of the deadly amoeba Naegleria fowleri. Christopher Rice, PhD, assistant professor of parasitology and principal investigator of the Rice Research Group, leads a research team seeking to discover and repurpose drugs against primary amoebic meningoencephalitis (PAM), a rare but typically fatal infection caused by Naegleria fowleri.

Purdue veterinary student receives Sir John D. Spurling Scholarship awarded by AKC Humane Fund

The AKC® Humane Fund, Inc.℠ has announced the 2026 recipients of the Sir John D. Spurling Scholarship, celebrating the human-canine bond, and one of the recipients is Purdue veterinary student Tiffany Chang of the Class of 2027. Chang is one of only five students chosen for the scholarships.

Purdue Veterinary Medicine Unites with Purdue United Way Campaign

With the goal of raising $700,000 by November 4 to support local nonprofit organizations that help individuals and families in Greater Lafayette, the Purdue United Way campaign took off September 23 with an official campaign launch on the front lawn of the Purdue Memorial Union. Purdue Veterinary Medicine, along with the university’s other colleges and units, will participate with the help of PVM faculty and staff ambassadors working to make it easy for people in the college to respond, whether by giving, or by indicating that they do not wish to give. As part of the PVM drive to support the campaign, Dean Bret Marsh and his wife, Polly, are contributing a match for campaign contributions from college faculty and staff. Additionally, a drawing will be held to select winners from those who contribute.